Search
for
Sort by
Research 121–150 of 1000+
- A97 TACROLIMUS-ASSOCIATED HEMOLYTIC UREMIC SYNDROME IN A PEDIATRIC LIVER TRANSPLANT RECIPIENT
- Forum
- Safety and use of oral minoxidil in pediatric patients: a systematic review and meta-analysis
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Alopecia in three women of southeast asian descent with chronic renal failure: Possible association with erythropoietin use
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Life Events Preceding Alopecia Areata Onset—a Descriptive Retrospective Cohort Study Focusing on Strain
- Real-world Experience to Understand the Use and Efficacy of Sebamed® Anti-Hair-Loss Shampoo in Managing Hair Fall
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic Adverse Events from Cancer Treatments
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Reporting on Adverse Clinical Events
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Diagnosing Vascular Causes of Renal Failure
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Alopecia prevention during chemotherapy: from the benchmark to real clinical practice. A prospective study
- 12-O-Tetradecanoylphorbol-13-acetate Induces Apoptosis in Renal Epithelial Cells through a Growth Signal Conflict Which Is Prevented by Activated ras1
- Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis